Please enter the email address you used to register, then we will send you a link to choose a new password
ENDRA Lifesciences filed a 13G form showing that S.H.N. Financial Investments had a 9.99% passive stake in the company.
- SEC Filing
https://data.epo.org/publication-server/publications/pdf?path=2024/24/DOC/EPNWB1/EP20856500NWB1/EP20856500NWB1.pdf
Ascendiant Capital analyst Edward Woo maintains ENDRA Life Sciences (NASDAQ:NDRA) with a Buy and lowers the price target fro...